Vaccine development for bacterial pathogens: Advances, challenges and prospects.

Area of Science:

• Microbiology and Immunology
• Vaccinology
• Infectious Diseases

Background:

• Antimicrobials have been crucial for treating infectious diseases, but the rise of multidrug-resistant (MDR) pathogens poses a significant global health challenge.
• Antimicrobial resistance (AMR) threatens the efficacy of existing treatments, necessitating alternative strategies for disease prevention and control.

Purpose of the Study:

• To review opportunities and advancements in vaccine discovery and development targeting bacterial pathogens.
• To analyze the impact of existing vaccines and the potential of those in development against MDR pathogens.
• To critically evaluate challenges in vaccine development and integration, particularly in low-income countries.

Main Methods:

• Comprehensive review of current literature on vaccine technologies, including reverse vaccinology, structural biology, nucleic acid vaccines, and nanomaterials.
• Analysis of preclinical and clinical trial data for vaccines targeting bacterial pathogens.
• Evaluation of the impact of antimicrobial resistance (AMR) on global health, with a focus on sub-Saharan Africa.

Main Results:

• Emerging vaccine technologies show promise for developing efficient vaccines against challenging bacterial pathogens.
• Several vaccines are in various stages of development, offering potential new tools against AMR.
• Significant challenges remain in vaccine discovery, development, and equitable integration, especially in resource-limited settings.

Conclusions:

• Vaccines represent a critical and promising alternative strategy to combat the growing threat of antimicrobial resistance (AMR).
• Continued innovation in vaccine technology and strategic development are essential to overcome AMR.
• Addressing regional disparities in vaccine access and development is crucial for global health equity in combating infectious diseases.